Telling Your 340B Story: Defining and Communicating Value Clearly

340B Data Sharing and Operational Reality

Manufacturer data-sharing discussions often assume that the requested information has already been sent to payers. Katy Lees explains why that is not always true, especially when 340B eligibility is determined after claim adjudication through accumulation, qualification, and replenishment processes. This episode offers practical insight for leaders evaluating risk, oversight, and operational realities. Visit Virtue 340B’s website to access the full episode and choose your preferred listening or viewing platform.

Telling Your 340B Story: Defining and Communicating Value Clearly

Communicating the value of your 340B program requires more than data—it requires clarity, alignment, and consistency. Katy Lees outlines how organizations can articulate program impact, strengthen stakeholderunderstanding, and translate social ROI into meaningful insight. A practical discussion for leaders focused on compliance, oversight, and operational visibility. Visit Virtue 340B’s website to access the full episode and choose your preferred listening or viewing platform.

340B Patient Definition Under Fire: What Leaders Need to Know

The definition of a 340B “patient” is under legal scrutiny in AbbVie v. HHS, raising new questions about eligibility, audit risk, and oversight. Katy unpacks how outdated guidance, manufacturer challenges, and recent court rulings may reshape compliance expectations. This episode focuses on what leaders need to understand now to maintain clarity and defensibility. Visit Virtue 340B’s website to access the full episode and choose your preferred listening or viewing platform.

Understanding the 340B GPO Court Ruling

A federal court decision has vacated HRSA’s 2013 GPO policy, but what does that actually mean for your 340B program? Katy Lees unpacks the difference between inventory purchasing flexibility and ongoing compliance obligations, highlighting where risk remains. This episode focuses on practical implications for pharmacy operations, replenishment models, and audit exposure. Visit Virtue 340B’s website to access the full episode and choose your preferred listening or viewing platform.

340B Eligibility vs Registration Explained

A court ruling is redefining how 340B eligibility isinterpreted—separating it from OPAIS registration. Katy Lees explains what this means for offsite locations, how to establish a defensible eligibility date, and why documentation and alignment across teams now matter more than ever.This episode focuses on practical, governance-driven decision-making in a changing environment. Visit Virtue 340B’s website to access the full episode and choose your preferred listening or viewing platform.